Request for Covid-19 Impact Assessment of this Report
1. Pre-analytical phase which comprises of patient identification, test request registration and billing, sample collection, labeling and sample processing.
2. Analytical phasecomprises of properly calibrating the instruments and analysis of samples.
3. Post-analytical phase which includes all the processes that follow the testing of the samples like the validation of test results, transcription of results into the records, typing the results, printing, and dispatch of the results. Also, the data so generated needs to be stored. The samples also need to be stored for a specified period of time.
All these phases can have some activities automated.Lab automation in clinical diagnostics market can simplify operations and increase the reproducibility. Moreover, the hard work and time required for manual labor can be reduced or eliminated.
Market Dynamics
The rapidly growing demand for diagnostic testing along with shrinking labor force of laboratory professionals is one of the prime drivers for automation in clinical diagnostics market. Moreover, rising number of diagnosis, number of suppliers in the diagnostic market, need for consistency in quality and a high cost of error also act as growth drivers.
Lack of planning for technology development, low priority for lab automation among small and medium-sized laboratoriesand high initial setup cost put constraints on the market.
Market Segmentation
The global lab automation market is segmented on the basis of:
--> Equipment and software (automated liquid handling, microplate readers, standalone robots, software and informatics, ASRS)
--> Type of automation (modular automation and total lab automation), by end users (biotech and pharma, hospitals and private labs, academics and research institutes).
Geographic Analysis
North America and Europe lead the global lab automation clinical diagnostics marketalong withCanada and Japan. Asia - Pacific and Latin American countries represent emerging markets.
Key Players
Some of the major players in the market include Beckman Coulter Inc, Bio-Rad Laboratories Inc, Eppendorf, Caliper Life Sciences, Abbott Diagnostics, Siemens Healthcare and Roche Diagnostics.
Report Contents:
> Market segments
> Market Drivers, Restraints and Opportunities
> Market Size & Forecast 2016 to 2022
> Supply & Demand Value Chain
> Market - Current Trends
> Competition & Major Companies
> Technology and R&D Status
> Porters Five Force Analysis
> Strategic and Critical Success Factor Analysis of Key Players
Regional Analysis:
> North America
>> US and Canada
> Latin America
>> Mexico, Brazil, Argentina and Rest of Latin America
> Western Europe
>> EU5 (Germany, France, Italy, Spain, U.K.)
>> Nordic Countries (Denmark, Finland, Norway, and Sweden)
>> Benelux (Belgium, The Netherlands, and Luxembourg)
>> Rest of Western Europe
> Eastern Europe
>> Russia
>> Poland
>> Rest of Eastern Europe
> Asia Pacific
>> China
>> India
>> Japan
>> Australia and New Zealand
>> Rest of Asia Pacific
> Middle East and Africa
>> GCC countries (Saudi Arabia, Oman, Qatar, Bahrain, UAE and Kuwait)
>> South Africa
>> North Africa
>> Rest of Middle East and Africa
This report is an elaborate aggregation of primary inputs from industry experts and participants across the supply chain. It provides details on market segmentation which is derived from several product mapping exercises, macroeconomic parameters and other qualitative and quantitative insights. The impact of all such factors is delivered across multiple market segments and geographies.
Report Highlights:
> Detailed Historical Overview (Market Origins, Product Launch Timeline, etc.)
> Consumer and Pricing Analysis
> Market dynamics of the industry
> Market Segmentation
> Estimated Market Sizing in terms of volume and value
> Recent trends in Market and impact
> Research Status and Technology Overview
> Extensive Industry Structure Coverage
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...